Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
When stacking, many clinicians reduce each peptide by 2550 % from its standalone dose because of the additive effect
Other causes include strict vegan diets, malabsorption disorders (coeliac disease, Crohn's disease), gastrointestinal surgery, and long-term use of medications such as metformin or proton pump inhibitors
We reference the COA to determine the verified concentration and purity of each product, regardless of what the label or product image indicates
Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture
